A Plant-Based diet, tailored to local tastes, may tame inflammation
NCT ID NCT07728877
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This pilot trial tests whether a short-term, culture-tailored plant-based diet is feasible for healthy adults in Taiwan and whether it can improve markers of inflammation and metabolism. Thirty generally healthy omnivores will receive either a plant-based or general diet for two weeks, then switch after a washout period. The study focuses on recruitment, adherence, and satisfaction, while also measuring inflammatory markers like C-reactive protein and interleukin-6 as early indicators of potential benefit.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a culture-tailored plant-based diet provided as boxed takeout meals on workdays
- What this could lead to
- If successful, this could pave the way for larger studies on how plant-based diets affect inflammation and metabolism in healthy people.
- What could go wrong
- This is a small pilot trial with only 30 participants, so results may not apply broadly. The diet is short-term and highly controlled, which may not reflect real-world adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Jun 2023
- Finished
-
Sep 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 64 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Geneally halthy adults who followed an omnivorous diet 2. Willing to adhere to the study interventions Exclusion Criteria: 1. Current treatment for diabetes, cancer, or immune disorders requiring dietary restrictions 2. Participation in any dietary or exercise program within the previous 6 months 3. Antibiotic therapy, non-steroidal anti-inflammatory drug use, or any surgery within the previous 3 months 4. Shift work 5. Habitual consumption of probiotics or fermented dairy products in daily or occasional frequency 6. Habitual alcohol intake exceeding the recommended daily limits as 20 g for males and 10 g for females
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dietary habits are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hualien Amed Forces General hospital
Hualien City, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a protein powder with creatine and fiber boost everyday Well-Being?
- Green tech or hidden stress? bus Drivers' hearts monitored behind the wheel
- Shout it out: can growls and screams raise pain tolerance?
- Scientists probe why brain stimulation works for some and not others
- Tiny doses, big questions: how does the body handle this prodrug?
- First human test of CM583: can this biologic pass the safety check?